APA (7th ed.) Citation

YC, F., D, M., M, G., K, B., D, H., EK, H., . . . M, S. G. (2025). Moderate-high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry, 97(1), 50. https://doi.org/10.1136/jnnp-2025-336513

Chicago Style (17th ed.) Citation

YC, Foong, et al. "Moderate-high Efficacy Disease-modifying Therapies Reduce Relapse Risk in Late-onset Multiple Sclerosis." Journal of Neurology, Neurosurgery, and Psychiatry 97, no. 1 (2025): 50. https://doi.org/10.1136/jnnp-2025-336513.

MLA (9th ed.) Citation

YC, Foong, et al. "Moderate-high Efficacy Disease-modifying Therapies Reduce Relapse Risk in Late-onset Multiple Sclerosis." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 97, no. 1, 2025, p. 50, https://doi.org/10.1136/jnnp-2025-336513.